LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
WASHINGTON, D.C. - Crowell & Moring LLP has announced the addition of partner James K. Stronski to the firm's Intellectual Property Group.
Based in the New York office, Stronski is an intellectual property litigator with extensive experience handling cases involving the so-called "Hatch-Waxman" Amendments to the Federal Food Drug & Cosmetic Act, as well as patent, trade secret, trademark, copyrights and unfair competition matters. Stronski will be joined by counsel Chiemi D. Suzuki. They join the firm from Frommer Lawrence & Haug LLP.
Stronski has been litigating cases primarily in federal courts nationwide for more than 20 years. He focuses his practice on the representation of generic pharmaceutical companies in patent litigation related to "Hatch-Waxman" matters. These particular cases involve challenges to pharmaceutical patents by companies wanting to introduce generic versions of patented drugs. Stronski has first chaired trials, evidentiary preliminary injunction and Markman hearings, and has argued before the Federal Circuit.
With considerable experience in both bench and jury trials, preliminary injunction motions and appellate practice, he has represented clients in a wide range of industries including pharmaceuticals, the Internet, consumer products, plastics, high-tech composites, and semiconductor manufacturing equipment. He also has first chaired cases, including through trial, before the Trademark Trial and Appeal Board, and advises clients on trademark infringement and clearance issues.
Stronski received his B.A. from Dartmouth College and his J.D. from Fordham Law School. After graduation from Fordham, Stronski completed a two-year clerkship for U.S. District Judge Shirley W. Kram of the Southern District of New York.
Suzuki, a New York-based counsel in the firm's Intellectual Property Group, focuses her practice on patent litigation, primarily related to pharmaceutical litigation under the Hatch-Waxman Act. Before private practice, Suzuki worked in technology transfer at the Office of Industrial Liaison at Mount Sinai School of Medicine. She received her B.A. from Bryn Mawr College, M.A. in Biotechnology from Columbia University, and her J.D. from University of California, Hastings College of Law.
Crowell & Moring LLP is an international law firm with nearly 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, Anchorage, London, and Brussels. For more information, visit www.crowell.com.